Renaissance Technologies - CYCLACEL PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CYCLACEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$107,000
+46.6%
279,094
+92.1%
0.00%
Q4 2015$73,000
-17.0%
145,294
+32.2%
0.00%
Q2 2015$88,000
+137.8%
109,900
+109.0%
0.00%
Q4 2014$37,00052,5780.00%
Other shareholders
CYCLACEL PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Redmile Group, LLC 1,077,465$3,179,0000.56%
DAFNA Capital Management LLC 44,300$131,0000.19%
Perceptive Advisors 350,000$1,033,0000.10%
Catalyst Capital Advisors LLC 43,000$127,0000.10%
TANG CAPITAL MANAGEMENT LLC 73,895$218,0000.09%
Invesco Private Capital 116,316$343,0000.04%
Allianz Asset Management GmbH 559,207$1,650,0000.00%
A.R.T. Advisors, LLC 19,507$57,0000.00%
BARCLAYS PLC 230,000$679,0000.00%
KNIGHT CAPITAL GROUP LLC 26,263$77,0000.00%
View complete list of CYCLACEL PHARMACEUTICALS INC shareholders